| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Singular Genomics Sys (NASDAQ:OMIC) reported its Q3 earnings results on Tuesday, November 14, 2023 at 04:01 PM.
Here's what investors need to know about the announcement.
Singular Genomics Sys beat estimated earnings by 18.42%, reporting an EPS of $-0.31 versus an estimate of $-0.38.
Revenue was up $462 thousand from the same period last year.
Last quarter the company beat on EPS by $0.02 which was followed by a 3.0% drop in the share price the next day.
Here's a look at Singular Genomics Sys's past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.37 | -0.35 | -0.43 | -0.41 |
| EPS Actual | -0.35 | -0.33 | -0.29 | -0.33 |
| Revenue Estimate | 1.15M | 1.24M | 760K | 70K |
| Revenue Actual | 505K | 863K | 765K | 0 |
To track all earnings releases for Singular Genomics Sys visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: OMIC
